Become one of the most demanded professionals today: specialize in Veterinary Oncology in Small Animals with this complete online Professional master’s degree”

The Professional master’s degree in Veterinary Oncology in Small Animals is a program developed by veterinary professionals with extensive experience in Small Animal Clinical Oncology both in the Clinical and Teaching areas.

All the professors on the program are clinicians and/or university professors with experience in both undergraduate and postgraduate training. The participating professors are specialized in different areas involved in Small Animal Oncology such as clinical oncologists, oncological surgeons, radiologists and anatomopathologists. The aim is to offer a Professional master’s degree that takes a multidisciplinary approach to oncology.

Small Animal Oncology is a subspecialty of Internal Medicine which has experienced great development in the last decades. Our professors are at the forefront of the latest diagnostic techniques and treatment of oncologic diseases in small animals. Due to their specialized training, they have designed a useful, practical program adapted to the current situation, an increasingly demanding and specialized reality.

The teaching team imparts specialized knowledge in each of the aspects covered by Veterinary Oncology, starting from tumor biology, with a general approach to oncology patients from the point of view of clinical oncology, oncologic surgery, specialized veterinary practice in diagnostic imaging and anatomo-pathology, including an exhaustive study of the most frequent types of tumors, reaching the most complex procedures and rare diseases. This program specializes general practitioners in veterinary oncology in an area that is increasingly in demand, partly due to its prevalence, and partly to the specialization this area requires and demands. The modules gradually present established knowledge, starting with the understanding of tumor biology, the approach to oncology patients, the main diagnostic and treatment techniques used in cancer, and ending with the development of specific tumors. It compiles the author's experience, without forgetting scientific rigor and the most important updates based on evidence. It addresses the diseases, the action protocols and the integral approach to patients, considering the disease, the patient and the owner in line with evidence-based medicine. All the modules include a large amount of multimedia material: photos, videos, diagrams, imaging techniques and surgery, all of which are crucial in the specialty.

As it is an online Master's Degree, the student is not conditioned by fixed schedules, nor does he/she need to move to another physical location. All of the content can be accessed at any time of the day, so you can balance your working or personal life with your academic life.  

You will evaluate the diagnostic and therapeutic approach in injection site associated sarcomas in cats from professionals with years of experience”

This Professional master’s degree in Veterinary Oncology in Small Animals contains the most complete and up-to-date scientific program on the market. The most important features include:

• The latest technology in online teaching software
• A highly visual teaching system, supported by graphic and schematic contents that are easy to assimilate and understand
• Practical cases presented by practising experts
• State-of-the-art interactive video systems
• Teaching supported by telepractice
• Continuous updating and recycling systems
•  Autonomous learning: full compatibility with other occupations
• Practical exercises for self-evaluation and learning verification
• Support groups and educational synergies: questions to the expert, debate and knowledge forums
• Communication with the teacher and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection
• Supplementary documentation databases are permanently available, even after the course

Get a complete and adequate qualification in Veterinary Oncology in Small Animals with this highly effective Professional master’s degree and pave new paths to your professional advancement”

Our teaching staff is made up of professionals from different fields related to this specialty. That way, TECH ensures to offer the updating objective it intends to provide. A multidisciplinary team of professionals trained and experienced in different environments, who will cover the theoretical knowledge in an efficient way, but, above all, will bring the practical knowledge from their own experience to the course: one of the differential qualities of this course.

This mastery of the subject is complemented by the effectiveness of the methodological design used in this Professional master’s degree in Veterinary Oncology in Small Animals. Developed by a multidisciplinary team of e-learning experts, it integrates the latest advances in educational technology. That way, students will study with a range of easy-to-use and versatile multimedia tools that will give them the necessary skills needed during training

The design of this program is based on Problem-Based Learning: an approach that views learning as a highly practical process. To achieve this remotely, TECH will use telepractice: with the help of an innovative interactive video system and Learning from an Expert, the student will be able to acquire the knowledge as if they were facing the scenario they are learning at that moment. A concept that will allow students to integrate and memorize what they have learnt in a more realistic and permanent way.

This program will give you a sense of confidence when practising veterinary medicine, which will help you grow both personally and professionally"

Learn in an efficient way, with a real qualification objective, with this unique Professional master’s degree for its quality and price, in the online teaching market"

The contents for this Professional master’s degree have been developed by the different experts on the program, with a clear purpose: to ensure that our students acquire each and every one of the necessary skills to become true experts in this field.
A complete and well-structured program will take you to the highest standards of quality and success.  

A complete program that will take you through the exhaustive knowledge necessary to intervene as a specialist in theoretical and practical aspects of Veterinary Oncology in Small Animals”

Module 1. Introduction to Oncology. Etiology, Biology and Epidemiology of Cancer. Anatomopathologic Diagnosis

1.1. Etiology of Cancer

1.1.1. Genetic Factors
1.1.2. Chemical, Physical and Hormonal Factors
1.1.3. Viral Origin

1.2. Biology of Cancer: Metastasis

1.2.1. Normal Cellular Cycle
1.2.2. Tumor Cells
1.2.3. Metastasis

1.3. Epidemiology and Evidence-Based Medicine: Translational Medicine

1.3.1. Epidemiological Terms
1.3.2. Factors Linked to Cancer
1.3.3. Translational Medicine

1.4. Approach to Cancer Patients (I)

1.4.1. Cancer Patient Overview
1.4.2. Initial Interview
1.4.3. Physical Exploration

1.5. Approach to Cancer Patients (II)

1.5.1. Diagnostic Techniques
1.5.2. Therapeutic Approach
1.5.3. Concomitant Pathologies

1.6. Cytology (I)

1.6.1. Cytological Sampling Technique
1.6.2. Most Frequent Stains in Cytological Diagnosis
1.6.3. Principle of Cytological Interpretation

1.7. Cytology (II)

1.7.1. Delivery Protocol for Cytological Samples
1.7.2. Epithelial Tumors
1.7.3. Mesenchymal Tumors

1.8. Cytology (III)

1.8.1. Round Cell Tumours
1.8.2. Metastatic Tumors and Cavity-Exfoliating Tumors
1.8.3. Interpreting Cytology Reports

1.9. Pathological Anatomy (I): Biopsy and Specimen Referral

1.9.1. Biopsy Techniques
1.9.2. How to Refer a Specimen Properly?
1.9.3. Interpreting Histopathological Reports

1.10. Pathological Anatomy (II): Interpreting Histological Reports

1.10.1. Immunohistochemistry Techniques and Molecular Biology
1.10.2. Utility and Advantages in Oncology Management
1.10.3. Tumor Markers

Module 2. Cancer Diagnosis. Imaging and Molecular Diagnostic Techniques. Chemotherapy, Electrochemotherapy and Molecular/Targeted Therapy

2.1. Diagnostic Imaging in Cancer Patients (I)

2.1.1. Introduction to Imaging Techniques in Oncology

2.1.1.1. Radiology
2.1.1.2. Ultrasound
2.1.1.3. Computerized Tomography
2.1.1.4. Magnetic Resonance

2.2. Diagnostic Imaging in Cancer Patients (II)

2.2.1. Diagnostic Imaging Techniques in Digestive Tract Neoplasms 
2.2.2. Imaging Techniques in Respiratory System Neoplasms
2.2.3. Diagnostic Imaging Techniques in Urinary System Neoplasms
2.2.4. Diagnostic Imaging Techniques in Hepatopoietic Neoplasms

2.3. Diagnostic Imaging in Cancer Patients (III)

2.3.1. Diagnostic Imaging Techniques in Cutaneous Neoplasms
2.3.2. Diagnostic Imaging Techniques in Nervous System Neoplasms
2.3.3. Diagnostic Imaging Techniques in Musculoskeletal Neoplasms

2.4. Molecular Diagnoses

2.4.1. Molecular Diagnostic Techniques
2.4.2. Quantification and Gene Expression
2.4.3. Personalized Therapy in Cancer

2.5. Principles of Surgical Oncology (I)

2.5.1. Pre-operative Considerations
2.5.2. Preoperative Approach
2.5.3. Biopsies and Sample Collecting

2.6. Principles of Surgical Oncology (II)

2.6.1. Surgical Considerations
2.6.2. Definition of Surgical Margins
2.6.3. Cytoreductive and Palliative Surgeries
2.6.4. Post-operative Considerations

2.7. Chemotherapy (I)

2.7.1. What Is Chemotherapy?
2.7.2. Dosage
2.7.3. Species Characteristics

2.8. Chemotherapy (II)

2.8.1. Antitumor Antibiotics
2.8.2. Alkylating Agents
2.8.3. Usage Inhibitors

2.9. Electrochemotherapy

2.9.1. Basis of Electrochemotherapy
2.9.2. Neuroeducation Applications
2.9.3. New Horizons

2.10. Molecular/Targeted Therapy

2.10.1. Genetic Therapy
2.10.2. Tyrosine Kinase Inhibitors
2.10.3. Angiogenic Therapy
2.10.4. Metronomic Therapy
2.10.5. Emerging Therapeutic Agents

Module 3. Cancer Patient Treatment. Radiotherapy, Immunotherapy, Interventional Oncology. Complications in Oncological Therapy. Palliative Care

3.1. Radiotherapy (I)

3.1.1. Principles of Biological Tissue Radiation
3.1.2. Stereotactic Radiation
3.1.3. Effective Biological Dose

3.2. Radiotherapy (II)

3.2.1. Palliative Radiotherapy
3.2.2. Tumors Frequently Treated with Radiotherapy

3.3. Immunotherapy

3.3.1. Immune System Control
3.3.2. Immune System Control Therapies
3.3.3. Antibody Therapy
3.3.4. Future of Immunotherapy

3.4. Interventional Oncology

3.4.1. Material
3.4.2. Vascular Interventions
3.4.3. Non-Vascular Interventions

3.5. Complications in Oncological Therapy

3.5.1. Hematological Side Effects
3.5.2. Digestive Side Effects
3.5.3. Other Side Effects

3.6. Paraneoplastic Syndromes

3.6.1. What Is a Paraneoplastic Syndrome?
3.6.2. Hypercalcemia
3.6.3. Others

3.7. Oncologic Emergencies

3.7.1. What Is an Oncologic Emergency?
3.7.2. Most Frequent Oncologic Emergencies
3.7.3. Treating Oncologic Emergencies

3.8. Communication with Owners

3.8.1. How to Deliver the News
3.8.2. How to Face the End
3.8.3. How to Prepare Emotionally

3.9. Palliative Care: Pain Treatment in Oncologic Patients

3.9.1. Mechanisms that Generate Pain in Cancer Patients
3.9.2. Pain Assessment in Cancer Patients
3.9.3. Pain Treatment in Cancer Patients

3.10. Palliative Care: Nutritional Support for Cancer Patients

3.10.1. Metabolism in Cancer
3.10.2. Nutritional Assessment of Cancer Patients
3.10.3. Implementing Nutrition Plans for Cancer Patients

Module 4. Cutaneous and Subcutaneous Tumors

4.1. Skin Tumors (I)

4.1.1. Incidence
4.1.2. Etiology
4.1.3. Diagnosis

4.2. Skin Tumors (II)

4.2.1. Treatment
4.2.2. Prognosis
4.2.3. Considerations

4.3. Canine Mastocytoma (I)

4.3.1. Treatment
4.3.2. Prognosis
4.3.3. Considerations

4.4. Canine Mastocytoma (II)

4.4.1. Diagnosis
4.4.2. Staging
4.4.3. Prognostic Factors

4.5. Canine Mastocytoma (III)

4.5.1. Surgery
4.5.2. Radiotherapy
4.5.3. Chemotherapy

4.6. Canine Mastocytoma (IV)

4.6.1. Prognosis
4.6.2. Survival
4.6.3. New Challenges

4.7. Feline Mastocytoma (I)

4.7.1. Differential Considerations with Canine Mastocytoma
4.7.2. Diagnosis
4.7.3. Treatment

4.8. Sequence Tagged Site (I)

4.8.1. Epidemiology
4.8.2. Incidence
4.8.3. Types of Soft Tissue Sarcomas

4.9. Sequence Tagged Site (II)

4.9.1. Soft Tissue Sarcoma Diagnosis
4.9.2. Complementary Tests
4.9.3. Staging

4.10. Sequence Tagged Site (III)

4.10.1. Treatment of Soft Tissues Sarcoma
4.10.2. Medical Treatment of Soft Tissue Sarcoma
4.10.3. Prognosis

Module 5. Injection Site Sarcomas. Melanoma. Respiratory Tumors

5.1. Feline Injection Site Sarcoma

5.1.1. Prevalence and Etiology
5.1.2. Diagnosis
5.1.3. Treatment

5.2. Melanoma (I)

5.2.1. Etiology
5.2.2. Diagnosis
5.2.3. Staging

5.3. Melanoma (II)

5.3.1. Surgical Management
5.3.2. Medical Treatment
5.3.3. Special considerations

5.4. Skin Surgery (I)

5.4.1. Anatomy, Vascularization and Tension
5.4.2. Pathophysiology of Healing
5.4.3. Injuries: Types and Management

5.5. Skin Surgery (II)

5.5.1. Plasties and Subdermal Plexus Flaps
5.5.2. Pedicle and Muscle Flaps
5.5.3. Grafts

5.6. Respiratory Tumors (I): Nasal Plane

5.6.1. Incidence and Risk Factors
5.6.2. Diagnosis
5.6.3. Treatment

5.7. Respiratory Tumors (II): Nasal Cavity

5.7.1. Incidence and Risk Factors
5.7.2. Diagnosis
5.7.3. Treatment

5.8. Respiratory Tumors (III): Larynx and Trachea

5.8.1. Incidence and Risk Factors
5.8.2. Diagnosis
5.8.3. Treatment

5.9. Respiratory Tumors (IV): Pulmonary

5.9.1. Incidence and Risk Factors
5.9.2. Diagnosis
5.9.3. Treatment

5.10. Respiratory Surgery

5.10.1. Nasal Plane Surgery
5.10.2. Nasal Cavity Surgery
5.10.3. Laryngeal and Tracheal Surgery
5.10.4. Pulmonary Lobectomy

Module 6. Digestive Tract Tumors. Mesothelioma

6.1. Digestive Tract Tumors (I): Oral Cavity I

6.1.1. Symptoms
6.1.2. Diagnosis
6.1.3. Treatment

6.2. Digestive Tract Tumors (II): Oral Cavity II

6.2.1. Symptoms
6.2.2. Diagnosis
6.2.3. Treatment

6.3. Digestive Tract Tumors (III): Esophagus, Stomach, Exocrine Pancreas

6.3.1. Symptoms
6.3.2. Diagnosis
6.3.3. Treatment

6.4. Digestive Tract Tumors (IV): Intestine

6.4.1. Symptoms
6.4.2. Diagnosis
6.4.3. Treatment

6.5. Digestive Tract Tumors (V): Nasal Sac Tumors

6.5.1. Symptoms
6.5.2. Diagnosis
6.5.3. Treatment

6.6. Digestive Tract Tumors (VI): Liver Tumors

6.6.1. Prevalence and Etiology
6.6.2. Diagnosis
6.6.3. Treatment

6.7. Digestive Surgery (I)

6.7.1. Anatomy
6.7.2. Principles of Digestive Surgery

6.8. Digestive Surgery (II)

6.8.1. Gastric Surgery
6.8.2. Intestinal Surgery

6.9. Digestive Surgery (III)

6.9.1. Liver Surgery

6.10. Mesothelioma

6.10.1. Diagnosis
6.10.2. Treatment

Module 7. Endocrine System Tumors. Breast Tumors. Ophthalmologic Tumors

7.1. Endocrine System Tumors (I): Adrenal Glands

7.1.1. Epidemiology
7.1.2. Diagnosis
7.1.3. Treatment

7.2. Endocrine System Tumors (II): Thyroid

7.2.1. Epidemiology
7.2.2. Diagnosis
7.2.3. Treatment

7.3. Endocrine System Tumors (III): Insulinoma

7.3.1. Epidemiology
7.3.2. Diagnosis
7.3.3. Treatment

7.4. Endocrine System Tumors (IV): Pituitary Tumors

7.4.1. Epidemiology
7.4.2. Diagnosis
7.4.3. Treatment

7.5. Endocrine Surgery

7.5.1. Adrenal Surgery
7.5.2. Thyroid Surgery
7.5.3. Pancreas Surgery

7.6. Breast Tumors: Canines (I)

7.6.1. Epidemiology
7.6.2. Risk Factors
7.6.3. Diagnosis

7.7. Breast Tumors: Canines (II)

7.7.1. Surgical Management
7.7.2. Medical Treatment
7.7.3. Prognosis

7.8. Breast Tumors: Felines (III)

7.8.1. Epidemiology
7.8.2. Diagnosis
7.8.3. Treatment

7.9. Ophthalmologic Tract Tumors (I)

7.9.1. Epidemiology
7.9.2. Clinical diagnosis
7.9.3. Complementary Tests

7.10. Ophthalmologic Tract Tumors (II)

7.10.1. Surgical Management
7.10.2. Medical Treatment

Module 8. Genitourinary Tumors. Nervous System Tumours

8.1. Female Reproductive System Tumors

8.1.1. Epidemiology
8.1.2. Diagnosis
8.1.3. Treatment

8.2. Male Reproductive System Tumors

8.2.1. Epidemiology
8.2.2. Diagnosis
8.2.3. Treatment

8.3. Urinary System Tumors (I)

8.3.1. Renal Tumors
8.3.2. Diagnosis
8.3.3. Treatment

8.4. Urinary System Tumors (II)

8.4.1. Urinary Bladder Tumors
8.4.2. Diagnosis
8.4.3. Treatment

8.5. Genitourinary Surgery (I)

8.5.1. General Principles of Reproductive System Surgery
8.5.2. Surgical Techniques in the Male Genital Tract
8.5.3. Surgical Techniques in the Female Genital Tract

8.6. Genitourinary Surgery (II)

8.6.1. Kidney Surgical Techniques
8.6.2. Ureter Surgical Techniques
8.6.3. Bladder Surgical Techniques
8.6.4. Urethra Surgical Techniques

8.7. Transmissible Venereal Tumor

8.7.1. Incidence and Pathology
8.7.2. Diagnosis
8.7.3. Treatment

8.8. Nervous System Tumors (I)

8.8.1. Brain Tumors
8.8.2. Diagnosis
8.8.3. Treatment

8.9. Nervous System Tumors (II)

8.9.1. Spinal Cord Tumors
8.9.2. Diagnosis
8.9.3. Treatment

8.10. Nervous System Surgery

8.10.1. Surgical Techniques for the Approach to Intracranial Tumors
8.10.2. Surgical Techniques for the Approach to Spinal Cord Tumors
8.10.3. Frequent Complications in Nervous System Surgery

Module 9. Hematopoietic Tumors

9.1. Hematopoietic System Tumors (I): Canine Lymphoma (I)

9.1.1. Etiology
9.1.2. Classification and Pathology
9.1.3. Clinical Signs
9.1.4. Diagnosis
9.1.5. Clinical Status

9.2. Hematopoietic System Tumors (II): Canine Lymphoma (II)

9.2.1. Multicentric Lymphoma Treatment

9.2.1.1. Re-Induction and Salvage Chemotherapy
9.2.1.2. Strategies to Improve Treatment Effectiveness
9.2.1.3. Immunotherapy and Other Treatments

9.3. Hematopoietic System Tumors (III): Canine Lymphoma (III)

9.3.1. Extranodal Lymphoma Treatment
9.3.2. Canine Lymphoma Prognosis

9.4. Hematopoietic System Tumors (IV): Canine Lymphoma (IV)

9.4.1. Lymphocytic Leukemia
9.4.2. Incidence, Etiology, Pathology and Classification
9.4.3. Clinical Signs and Diagnosis
9.4.4. Treatment
9.4.5. Prognosis

9.5. Hematopoietic System Tumors (V): Feline Lymphoma (I)

9.5.1. Incidence, Etiology and Pathology in Feline Lymphoma
9.5.2. Gastrointestinal / Dietary Lymphoma

9.6. Hematopoietic System Tumors (VI): Feline Lymphoma (II)

9.6.1. Peripheral Lymph Node Lymphoma

9.6.1.1. Mediastinal Lymphoma

9.6.2. Extranodal Lymphoma

9.6.2.1. Nasal Lymphoma
9.6.2.2. Renal Lymphoma
9.6.2.3. Central Nervous System Lymphoma
9.6.2.4. Cutaneous Lymphoma
9.6.2.5. Subcutaneous Lymphoma
9.6.2.6. Laryngeal Lymphoma
9.6.2.7. Ocular Lymphoma
9.6.2.8. Felines Lymphoma Prognosis

9.7. Hematopoietic System Tumors (VII): Feline Lymphoma (III)

9.7.1. Feline Leukemia, Myeloproliferative Disorders and Myelodysplasia

9.8. Hematopoietic System Tumors (VIII)

9.8.1. Canine Acute Myeloid Leukemia, Myeloproliferative Neoplasms, and Myelodysplasia

9.8.1.1. Incidence, Risk Factors
9.8.1.2. Pathology
9.8.1.3. Acute Myeloid Leukemia

9.8.2. Myeloproliferative Neoplasms

9.8.2.1. Polycythemia Vera
9.8.2.2. Chronic Myelogenous Leukemia

9.8.2.2.1. Eosinophilic and Basophilic Leukemia
9.8.2.2.2. Essential Thrombocythemia/Primary Thrombocytosis

9.9. Other Bone Marrow Disorders

9.9.1. Myelofibrosis
9.9.2. Myelodysplastic Syndromes

9.10. Hematopoietic System Tumors (IX): Plasma Cell Tumors

9.10.1. Multiple Myeloma
9.10.2. Solitary and Extramedullary Plasmacytic Tumors
9.10.3. Canine Histiocytic Disease: Feline Histiocytic Disease
9.10.4. Canine Histiocytic Disease

9.10.4.1. Cutaneous Histiocytoma
9.10.4.2. Cutaneous Langerhans Cell Histiocytosis
9.10.4.3. Reactive Histiocytosis

9.10.5. Histiocytic Sarcoma
9.10.6. Hemophagocytic Histiocytic Sarcoma
9.10.7. Feline Histiocytic Disease
9.10.8. Feline Histiocytic Sarcoma
9.10.9. Progressive Feline Histiocytosis
9.10.10. Pulmonary Langerhans Cell Histiocytosis

Module 10. Hemangiosarcoma. Thymoma. Cardiac Tumors. Musculoskeletal Tumors

10.1. Hemangiosarcoma (I)

10.1.1. Incidence and Risk Factors
10.1.2. Etiology
10.1.3. Diagnosis

10.2. Hemangiosarcoma (II)

10.2.1. Treatment
10.2.2. Prognosis

10.3. Spleen Surgery

10.3.1. Spleen Surgery Techniques

10.4. Thymoma

10.4.1. Diagnosis
10.4.2. Treatment

10.5. Cardiac Tumors

10.5.1. Diagnosis
10.5.2. Treatment

10.6. Thoracic Surgery (I)

10.6.1. Anatomy
10.6.2. Particularities of Thoracic Surgery
10.6.3. Thoracic Cavity Approaches

10.7. Thoracic Surgery (II)

10.7.1. Pericardiocentesis
10.7.2. Pericardiectomy

10.8. Musculoskeletal Tumors (I)

10.8.1. Osteosarcoma
10.8.2. Incidence and Risk Factors
10.8.3. Etiology
10.8.4. Diagnosis
10.8.5. Treatment

10.9. Musculoskeletal Tumors (II)

10.9.1. Other Bone Tumors
10.9.2. Feline Bone Tumors

10.10. Musculoskeletal Surgery

10.10.1. Biopsy Technique
10.10.2. Surgical Technique for Amputations 

Make the most of this opportunity to learn about the latest advances in this area in order to apply it to your daily practice"